Cited by 37

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

A sequence variant in human KALRN impairs protein function and coincides with reduced cortical thickness

Russell, Theron A., Blizinsky, Katherine D., Cobia, Derin J., Cahill, Michael E., Xie, Zhong, Sweet, Robert A., Duan, Jubao, Gejman, Pablo V., Wang, Lei, Csernansky, John G., Penzes, Peter·2014·Nature Communications

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms5858

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 16 references

Research works printed but not linked: 54

  1. Lamprecht, R. Actin cytoskeleton in memory formation. Prog. Neurobiol. 117, 1–19 (2014). · DOI
  2. Penzes, P. & Rafalovich, I. Regulation of the actin cytoskeleton in dendritic spines. Adv. Exp. Med. Biol. 970, 81–95 (2012). · DOI
  3. Lamprecht, R. & LeDoux, J. Structural plasticity and memory. Nat. Rev. Neurosci. 5, 45–54 (2004). · DOI · Paper page
  4. Bennett, M. R. Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss. Prog. Neurobiol. 95, 275–300 (2011). · DOI
  5. Tolias, K. F., Duman, J. G. & Um, K. Control of synapse development and plasticity by Rho GTPase regulatory proteins. Prog. Neurobiol. 94, 133–148 (2011). · DOI · Paper page
  6. Carlisle, H. J. & Kennedy, M. B. Spine architecture and synaptic plasticity. Trends Neurosci. 28, 182–187 (2005). · DOI
  7. Penzes, P. & Jones, K. A. Dendritic spine dynamics--a key role for kalirin-7. Trends Neurosci. 31, 419–427 (2008). · DOI · Paper page
  8. Johnson, R. C., Penzes, P., Eipper, B. A. & Mains, R. E. Isoforms of kalirin, a neuronal Dbl family member, generated through use of different 5'- and 3'-ends along with an internal translational initiation site. J. Biol. Chem. 275, 19324–19333 (2000). · DOI
  9. Rabiner, C. A., Mains, R. E. & Eipper, B. A. Kalirin: a dual Rho guanine nucleotide exchange factor that is so much more than the sum of its many parts. Neuroscientist 11, 148–160 (2005). · DOI
  10. Penzes, P. et al. An isoform of kalirin, a brain-specific GDP/GTP exchange factor, is enriched in the postsynaptic density fraction. J. Biol. Chem. 275, 6395–6403 (2000). · DOI
  11. Penzes, P. et al. The neuronal Rho-GEF Kalirin-7 interacts with PDZ domain-containing proteins and regulates dendritic morphogenesis. Neuron 29, 229–242 (2001). · DOI
  12. Xie, Z., Cahill, M. E. & Penzes, P. Kalirin loss results in cortical morphological alterations. Mol. Cell. Neurosci. 43, 81–89 (2010). · DOI · Paper page
  13. Hayashi-Takagi, A. et al. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 13, 327–332 (2010). · DOI · Paper page
  14. Cahill, M. E. et al. Control of interneuron dendritic growth through NRG1/erbB4-mediated kalirin-7 disinhibition. Mol. Psychiatry 17, 1, 99–107 (2012).
  15. Cahill, M. E. et al. Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc. Natl Acad. Sci. USA 106, 13058–13063 (2009). · DOI · Paper page
  16. Kushima, I. et al. Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility. Schizophr. Bull. 38, 552–560 (2012). · DOI · Paper page
  17. Rubio, M. D., Haroutunian, V. & Meador-Woodruff, J. H. Abnormalities of the Duo/Ras-related C3 botulinum toxin substrate 1/p21-activated kinase 1 pathway drive myosin light chain phosphorylation in frontal cortex in schizophrenia. Biol. Psychiatry 71, 906–914 (2012). · DOI
  18. Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248–249 (2010). · DOI · Paper page
  19. Penzes, P. & Cahill, M. E. Deconstructing signal transduction pathways that regulate the actin cytoskeleton in dendritic spines. Cytoskeleton (Hoboken) 69, 426–441 (2012). · DOI
  20. Iafrate, A. J. et al. Detection of large-scale variation in the human genome. Nat. Genet. 36, 949–951 (2004). · DOI · Paper page
  21. Duan, J., Sanders, A. R. & Gejman, P. V. Genome-wide approaches to schizophrenia. Brain Res. Bull. 83, 93–102 (2010). · DOI
  22. Sebat, J., Levy, D. L. & McCarthy, S. E. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet. 25, 528–535 (2009). · DOI · Paper page
  23. Glessner, J. T. et al. Strong synaptic transmission impact by copy number variations in schizophrenia. Proc. Natl Acad. Sci. USA 107, 10584–10589 (2010). · DOI
  24. Li, N. et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959–964 (2010). · DOI · Paper page
  25. Lee, S. H. et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984–994 (2013). · DOI · Paper page
  26. Andreassen, O. A. et al. Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci. Mol. Psychiatry doi:10.1038/mp.2013.195 (2014). · DOI
  27. Andreassen, O. A. et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am. J. Hum. Genet. 92, 197–209 (2013). · DOI · Paper page
  28. Silveira, J. M. & Seeman, M. V. Shared psychotic disorder: a critical review of the literature. Can. J. Psychiatry 40, 389–395 (1995). · DOI
  29. Herz, M. I. & Melville, C. Relapse in schizophrenia. Am. J. Psychiatry 137, 801–805 (1980). · DOI
  30. Meda, S. A. et al. Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia. Proc. Natl Acad. Sci. USA 111, E2066–E2075 (2014). · DOI · Paper page
  31. Cahill, M. E. et al. Neuregulin1 signaling promotes dendritic spine growth through kalirin. J. Neurochem. 126, 625–635 (2013). · DOI
  32. Carless, M. A. et al. Impact of DISC1 variation on neuroanatomical and neurocognitive phenotypes. Mol. Psychiatry 16, 1096–1104 1063 (2011). · DOI
  33. Lee, F. H. et al. Disc1 point mutations in mice affect development of the cerebral cortex. J. Neurosci. 31, 3197–3206 (2011). · DOI
  34. Lepagnol-Bestel, A. M., Kvajo, M., Karayiorgou, M., Simonneau, M. & Gogos, J. A. A Disc1 mutation differentially affects neurites and spines in hippocampal and cortical neurons. Mol. Cell. Neurosci. 54, 84–92 (2013). · DOI
  35. Tosato, S. et al. Is neuregulin 1 involved in determining cerebral volumes in schizophrenia? Preliminary results showing a decrease in superior temporal gyrus volume. Neuropsychobiology 65, 119–125 (2012). · DOI
  36. Barros, C. S. et al. Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc. Natl Acad. Sci. USA 106, 4507–4512 (2009). · DOI · Paper page
  37. Meltzer, H. Y., Massey, B. W. & Horiguchi, M. Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia. Curr. Pharm. Biotechnol. 13, 1572–1586 (2012). · DOI
  38. Dean, B. Interpreting the significance of decreased cortical serotonin 2A receptors in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 1583–1584 author reply 1585–1586 (2009). · DOI
  39. Brunet-Gouet, E. et al. The study of social cognition with neuroimaging methods as a means to explore future directions of deficit evaluation in schizophrenia? Psychiatry Res. 190, 23–31 (2011). · DOI
  40. Gur, R. E. et al. Flat affect in schizophrenia: relation to emotion processing and neurocognitive measures. Schizophr. Bull. 32, 279–287 (2006). · DOI
  41. Karlsgodt, K. H. et al. Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Dev. Psychopathol. 20, 1297–1327 (2008). · DOI
  42. Rapoport, J. L. et al. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 56, 649–654 (1999). · DOI
  43. Huttenlocher, P. R. Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res. 163, 195–205 (1979). · DOI · Paper page
  44. Glantz, L. A. & Lewis, D. A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57, 65–73 (2000). · DOI · Paper page
  45. Selemon, L. D. & Goldman-Rakic, P. S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45, 17–25 (1999). · DOI · Paper page
  46. Lewis, D. A. & Sweet, R. A. Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J. Clin. Invest. 119, 706–716 (2009). · DOI
  47. Sullivan, P. F. et al. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol. Psychiatry 13, 570–584 (2008). · DOI
  48. Ikeda, M. et al. Genome-wide association study of schizophrenia in a Japanese population. Biol. Psychiatry 69, 472–478 (2011). · DOI
  49. Calabrese, D. R. et al. Cingulate gyrus neuroanatomy in schizophrenia subjects and their non-psychotic siblings. Schizophr. Res. 104, 61–70 (2008). · DOI
  50. Delawalla, Z. et al. Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia. Schizophr. Bull. 32, 525–537 (2006). · DOI
  51. Srivastava, D. P. et al. Rapid enhancement of two-step wiring plasticity by estrogen and NMDA receptor activity. Proc. Natl Acad. Sci. USA 105, 14650–14655 (2008). · DOI
  52. Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012). · DOI · Paper page
  53. Dale, A. M., Fischl, B. & Sereno, M. I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9, 179–194 (1999). · DOI · Paper page
  54. Desikan, R. S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31, 968–980 (2006). · DOI · Paper page

Cited by

Sorted by citations

See all 37

Metadata

Authors
Russell, T. A., Blizinsky, K. D., Cobia, D. J., Cahill, M. E., Xie, Z., Sweet, R. A., Duan, J., Gejman, P. V., Wang, L., Csernansky, J. G., & Penzes, P.
Venue
Nature Communications
Published
2014-09-16
Volume
5
Issue
1
ISSN
2041-1723
Cited by
37
References
16
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review